Orreco signs multi-year deal with the NBA’s Atlanta Hawks to provide AI driven bio-analytics
Sports Performance Company Orreco will work directly with Hawks Head of Basketball Operations and General Manager Travis Schlenk and Executive Director of Athletic Performance Chelsea Lane
Atlanta, GA – (July 2, 2019) – Pioneering biomarker and sports performance company Orreco has signed a multi-year exclusive agreement that will see the specialist company provide the Atlanta Hawks of the National Basketball Association with its cutting edge bio-analytics services.
Orreco, which counts both NBA franchises and individual players, English Premier League side Newcastle United FC and elite sports organizations such as USA Swimming and Red Bull High Performance as part of its client base, will immediately commence work with the Hawks Performance staff, led by Ms Chelsea Lane.
Under the new partnership, Orreco, a global leader in bio-analytics, will use its products called Zone and TrackOR – to help support and accelerate Atlanta Hawks player recovery, optimize performance and help further reduce the number of training and games lost to illness/injury.
Orreco has extensive experience within the NBA having worked for the past seven seasons with both franchises and individual NBA athletes.
This experience has made Orreco and its team of PhD scientists global leaders in basketball bio-analytics, developing a deep understanding of the relationship between biomarkers, wearable technology and performance analytics, understanding how to manage the “Rookie Wall”, and helping to prolong veteran players careers, while understanding the optimal workloads for a player’s body.
Ms Chelsea Lane, Atlanta Hawks Executive Director of Athletic Performance and Sports Medicine, said: “I am delighted that the Atlanta Hawks are partnering with Orreco for our bio-analytics. I selected Orreco as they are world-leaders in bio-analytics. They possess unrivalled expertise interpreting biomarker data and have critically peer-reviewed published science highlighting their work with elite athletes. Our goal is to help our players understand how their recovery status impacts their performance and using this data to truly individualize their training. We are very excited that Orreco has come on board as we at the Hawks enter a new chapter in our history.”
Dr Brian Moore, CEO of Orreco, said: “Our new partnership with the Atlanta Hawks is an exciting development for team Orreco. We look forward to working with Chelsea and her team supporting the Atlanta Hawks to make real-time data-driven decisions leveraging biomarkers and artificial intelligence. The combination of the Hawk’s ambition, coaching and playing talent, alongside Orreco’s expertise and industry-changing technology is a tremendously exciting prospect.”
For more information, contact Colin Morrissey at colin.morrissey@orreco.com
Orreco
Established in 2010, Orreco has offices in Los Angeles, London and Galway, Ireland. Orreco scientists analyse athlete data and deliver evidence-based, personalized strategies to improve recovery rates, optimize training response and protect against excessive fatigue and under-recovery. By keeping athletes in their peak performance zone, Orreco aims to reduce injury and illness risk for elite athletes and extend playing careers. Orreco scientists have been analysing athlete data for over 18 years, across 5 Olympics, in 16 different sports for over 2000 elite athletes. The team includes 16 PhDs, together they have 300+ peer-reviewed publications and continue to lead research globally in their fields. Orreco integrates sports science, data science and systems development and operates as a team within the team. Clients include teams and franchises in the NBA, NFL, MLB,NHL, EPL and individual athletes in Olympic sports including 35 medallists, F1 drivers and PGA tour players including 3 Major winners.
Visit www.orreco.com
